Xoma reported $-2063000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Agenus AGEN:US $ -34.34M 20.08M
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
Ardelyx ARDX:US $ -27.58M 4.9M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Celldex Therapeutics CLDX:US $ -22.45M 2.88M
Chimerix CMRX:US $ -24.75M 14.76M
Curis CRIS:US $ -15.1M 2.57M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Emergent Biosolutions EBS:US $ 37.3M 311M
Epizyme EPZM:US $ -49.63M 0.33M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Life Technologies LIFE:US $ -12.3M 3.76M
Macrogenics MGNX:US $ -63725000 8.44M
Novartis NOVN:VX SF 4552M 346M
Novartis NVS:US $ 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Prothena PRTA:US -37744000 4.89M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Teva Pharmaceutical Industries TEVA:US $ 1112M 176M
Xoma XOMA:US $ -2063000 32.43M
YTE INCY:US $ 144.1M 9.29M